Publicacions en col·laboració amb investigadors/es de Hospital Universitario de la Princesa (17)

2024

  1. Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study

    Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202

  2. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study

    Frontiers in Neurology , Vol. 15

  3. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine

    European Journal of Neurology, Vol. 31, Núm. 4

  4. Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world

    Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937

  5. Visual snow syndrome in patients with migraine: widening the clinical spectrum of the syndrome with permanent and episodic manifestations

    Neurological Sciences, Vol. 45, Núm. 9, pp. 4437-4444

2022

  1. Headache: What to ask, how to examine, and which scales to use. Recommendations of the Spanish Society of Neurology's Headache Study Group

    Neurologia, Vol. 37, Núm. 7, pp. 564-574

  2. Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients

    Cephalalgia, Vol. 42, Núm. 8, pp. 804-809

  3. Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain

    Neurologia

2021

  1. Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown

    Neurological Sciences, Vol. 42, Núm. 12, pp. 5087-5092

  2. Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine

    Pain medicine (Malden, Mass.), Vol. 22, Núm. 9, pp. 2079-2091

  3. Impact of the COVID-19 pandemic on the training of Spanish neurology residents

    Neurology Perspectives, Vol. 1, Núm. 2, pp. 124-130

2020

  1. Association Between Personality Traits and Onabotulinumtoxin A Response in Patients With Chronic Migraine

    Headache, Vol. 60, Núm. 1, pp. 153-161

  2. How and when to refer patients diagnosed with primary headache and craniofacial neuralgia in the Emergency department or Primary Care: Recommendations of the Spanish Society of Neurology's Headache Study Group

    Neurologia

2019

  1. CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA

    Journal of Headache and Pain, Vol. 20, Núm. 1

  2. Real world preventative drug management of migraine among Spanish neurologists

    Journal of Headache and Pain, Vol. 20, Núm. 1

  3. Self-reported periodontitis and migraine: results from a multicenter, cross-sectional survey in Spain

    Odontology, Vol. 107, Núm. 4, pp. 530-535

  4. Wearing off Response to OnabotulinumtoxinA in Chronic Migraine: Analysis in a Series of 193 Patients

    Pain Medicine (United States), Vol. 20, Núm. 9, pp. 1815-1821